Blood test 'detects breast cancer relapse early'
But charities warn there is a long way to go before the life-saving tests could be made available in hospitals

A free daily digest of the biggest news stories of the day - and the best features from our website
Thank you for signing up to TheWeek. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.
A simple blood test can accurately detect breast cancer relapses several months before hospital scans, researchers have discovered.
Scientists at London's Institute of Cancer Research have developed a test that can detect small amounts of residual cancer cells that have resisted therapy by looking for tumour DNA in the blood.
The study involved 55 early-stage breast cancer patients who had successfully undergone chemotherapy and surgery.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Their blood was tested at six-month intervals, and doctors were able to "very accurately" predict which patients were likely to suffer a relapse, The Guardian reports.
Patients who tested positive for circulating tumour DNA were 12 times more likely to relapse than those who tested negative and doctors were able to predict the return of the disease nearly eight months before it could be detected by scans.
“Ours is the first study to show that these blood tests could be used to predict relapse," said lead Dr Nicholas Turner, consultant medical oncologist at The Royal Marsden NHS Foundation Trust.
"We also used blood tests to build a picture of how the cancer was evolving over time, and this information could be invaluable to help doctors select the correct drugs to treat the cancer."
Breast cancer is the most prevalent form of the disease among women in Britain, with around 50,000 cases a year. By detecting the cancer earlier, doctors are able to begin treatment sooner and improve a patient's chances of survival.
Scientists say the testing could also potentially be applied to any cancer that has gone through initial treatment and for which there is a risk of relapse in the future.
Turner predicts it will be "some years yet" before the tests could be made available in hospitals, but his team hopes to bring the date closer by carrying out larger clinical trials next year.
However, Nick Peel, from Cancer Research UK, told the BBC that "there is some way to go before this could be developed into a test that doctors could use routinely, and doing so is never simple".
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.
Sign up to our 10 Things You Need to Know Today newsletter
A free daily digest of the biggest news stories of the day - and the best features from our website
-
The daily gossip: Man arrested in connection with shooting of Tupac Shakur, an OceanGate movie is in the works, and more
Feature The daily gossip: September 29, 2023
By Brendan Morrow Published
-
What to expect from an El Niño winter
The Explainer Things might be different thanks to this well-known weather phenomenon
By Devika Rao Published
-
The week’s best photojournalism
In Pictures A steaming volcano, a giant crater and more
By Anahi Valenzuela Published
-
What is a 'feminist approach' to cancer care?
The Explainer 800,000 women die from 'preventable' cancers each year due to 'patriarchy', landmark study finds
By Harriet Marsden, The Week UK Published
-
Good health news: seven surprising medical discoveries made in 2023
In Depth A fingerprint test for cancer, a menopause patch and the shocking impacts of body odour are just a few of the developments made this year
By The Week Staff Published
-
Five good-news cancer breakthroughs in 2023
In Depth Cancer-sniffing ants, ‘Bond villain’ DNA, and vaccine trials are just a few exciting developments in cancer research this year
By The Week Staff Published
-
mRNA technology and a vaccine for cancer
feature Cure is ‘in our grasp’ say the scientists behind the BioNTech Covid-19 jab
By The Week Staff Published
-
Do vegans live longer?
feature Plant-based lifestyles can drastically lower rates of some serious diseases
By Chas Newkey-Burden Published
-
Sanofi/GSK/Haleon: cancer fears prove hard to stomach
Business Briefing Shares of GlaxoSmithKline, Sanofi and the new GSK spin-off, Haleon, all fell sharply last week
By The Week Staff Published
-
The Week Unwrapped: Immunotherapy, unions and a house revival
podcast Can our immune systems help us fight cancer? Have unions finally cracked the tech sector? And is 90s house music making a comeback?
By The Week Staff Published
-
Neanderthal gene ‘caused up to a million Covid deaths’
Speed Read Genetic tweak found in one in six Britons means cells in the lungs are slower to launch defences
By The Week Staff Published